{"id":"dc071","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Pierre Fabre Medicament","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Pierre Fabre Medicament","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DC071","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:01:04.195460+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:01:11.125734+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DC071","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:01:11.474808+00:00"}},"allNames":["dc071"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"As a small molecule, dc071 is likely to interact with its target through non-covalent binding, potentially altering the target's conformation or activity. However, the specific details of this interaction are unknown due to the lack of available information."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=dc071","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dc071","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:31:22.027173","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:01:13.653849+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"dc071","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02382809","phase":"PHASE4","title":"Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction","status":"COMPLETED","sponsor":"Pierre Fabre Medicament","startDate":"2015-03","conditions":["Alveolar Osteitis"],"enrollment":414,"completionDate":"2016-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Pierre Fabre Medicament","relationship":"Original Developer"}],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Pierre Fabre Medicament","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"DC071","companyName":"Pierre Fabre Medicament","companyId":"pierre-fabre-medicament","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:01:13.653849+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}